The authors concluded that early oxytocin augmentation of labour was associated with an increase in spontaneous vaginal delivery. Further research was needed to obtain more robust conclusions. This was a generally well-conducted review. The authors' cautious conclusions reflected the evidence, but the small number of trials of uncertain quality should be borne in mind when interpreting the findings.
Searching
PubMed and EMBASE were searched through to February 2009 for publications in any language. Search terms were reported. The Trial Registry of the Cochrane Collaboration Pregnancy and Child Birth Review Groups was searched for unpublished trials.
Study selection
Randomised controlled trials (RCTs) that compared early augmentation of labour with oxytocin versus a more conservative form of management in pregnant women in labour who had not previously used oxytocin were eligible for inclusion. Only trials in which comparison groups received similar and standardised membrane management were eligible. Trials were required to measure at least one of the outcomes: caesarean delivery; spontaneous vaginal delivery; operative vaginal delivery; duration of labour; analgesia; hyperstimulation of labour; postpartum haemorrhage; maternal blood transfusion; antibiotic use; vaginal tears; and neonatal complications.
Included trials were conducted in UK, USA and Canada, Finland and South Africa and were of women in normal labour at randomisation, or women with prolonged labour (dystocia). Just over half the trials reported a single foetus with vertex or cephalic presentation. Most trials reported this to be the woman's first birth. Oxytocin was administered at various times across studies and commenced in women with a mean (or median) cervical dilatation of 5cm or less. Control groups received expectant management or ambulation, with oxytocin administered at a later stage (usually after four to eight hours) if necessary. Women in most trials underwent amniotomy.
Two reviewers independently screened studies for inclusion.
Assessment of study quality
Two reviewers independently assessed studies for selection, performance, detection and attrition bias (as defined by previously published criteria). Disagreements were resolved through referral to a third reviewer.
Data extraction
Two reviewers independently extracted dichotomous data to calculate relative risks (RRs) and 95% confidence intervals (CIs). Continuous data were extracted to calculate mean differences and 95% CIs. Primary authors were contacted for further data where necessary.
Methods of synthesis
A fixed-effect model was used to combine relative risks and mean differences, with 95% CIs. A random-effects model was used when there was evidence of statistical heterogeneity. Number needed to treat (NNT) was calculated. Statistical heterogeneity was assessed using the I 2 statistic.
Sensitivity analysis was undertaken by removal of trials that did not use amniotomy before randomisation and trials that compared oxytocin with ambulation.
